Total submissions: 3
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Eurofins Ntd Llc |
RCV000727272 | SCV000707123 | uncertain significance | not provided | 2017-03-22 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV002532556 | SCV003719632 | uncertain significance | Inborn genetic diseases | 2021-07-13 | criteria provided, single submitter | clinical testing | The c.551G>A (p.R184H) alteration is located in exon 4 (coding exon 1) of the PEX2 gene. This alteration results from a G to A substitution at nucleotide position 551, causing the arginine (R) at amino acid position 184 to be replaced by a histidine (H). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. |
Natera, |
RCV001829673 | SCV002083364 | uncertain significance | Zellweger spectrum disorders | 2020-01-24 | no assertion criteria provided | clinical testing |